Sort   by:  
 Page size 
TranscriptomicsscRNA-seq from Trex1 KO in tumor
Single-cell RNA-seq data for Trex1 WT and KO mice from the tumor. Used for manuscript in submission at Science Advances.
ORGANISM(S): Mus musculus 
2026-03-25 | E-MTAB-16526 | biostudies-arrayexpress
UnknownCEP192 localises mitotic Aurora-A activity by priming its interaction with TPX2.
Not available
S-EPMC11574021 | biostudies-literature
UnknownA nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study.
Not available
S-EPMC7575021 | biostudies-literature
UnknownLung adenocarcinoma promotion by air pollutants.
Not available
S-EPMC7614604 | biostudies-literature
UnknownAssociation of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Not available
S-EPMC4979321 | biostudies-literature
TranscriptomicsRNA velocity analysis of the PERFORM RNA-Seq dataset
For our RNA velocity study we used whole-blood RNA-Seq data generated from a 399 subset (patients with suspected infection) of the Personalized Risk assessment in Febrile illness to Optimize Real-life Management across the European Union (PERFORM) study cohort - a multi-country prospective observati...
ORGANISM(S): Homo sapiens 
2026-02-10 | E-MTAB-14728 | biostudies-arrayexpress
TranscriptomicsWhole genome characterisation of chemoresistant ovarian cancer [Illumina_450K_Methylation]
Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-...
ORGANISM(S): Homo sapiens 
2015-05-19 | E-GEOD-65820 | biostudies-arrayexpress
UnknownThe SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Not available
S-EPMC8047813 | biostudies-literature
UnknownThe SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Not available
S-EPMC8047799 | biostudies-literature
UnknownA large-scale study across the avian clade identifies ecological drivers of neophobia.
Not available
S-EPMC12520376 | biostudies-literature
Sort   by:  
 Page size